The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Understanding cancer and the anticancer activities of naphthoquinones – a review
Open accessAbstract
Naphthoquinone moieties are present in drugs such as doxorubicin which are used clinically to treat solid cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Lipid peroxidation: its mechanism, measurement, and significance
Halliwell, B., & Chirico, S. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.5.715s · Cited by 2,352
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Antioxidant enzymes and human diseases
MatÉs, J. M., Pérez-Gómez, C., & De Castro, I. N. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00075-2 · Cited by 2,099
ROS stress in cancer cells and therapeutic implications
Pelicano, H., Carney, D., & Huang, P. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.004 · Cited by 2,006
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,748
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
(2016) · Wiley eBooks · doi:10.1002/9781119000822 · Cited by 1,148
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,029
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
Free Radicals in Biology and Medicine
Kovacic, P. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750133 · Cited by 982
Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents
Kasai, H., & Nishimura, S. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.4.2137 · Cited by 945
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
Jagtap, P., & Szabó, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1718 · Cited by 896
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
(2005) · Advances in Cancer Research · doi:10.1016/s0065-230x(05)94002-5 · Cited by 823
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Cancer cell killing via ROS: To increase or decrease, that is the question
Wang, J., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7067 · Cited by 790
Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., & Cowan, K. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66748-1 · Cited by 789
The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans
P.B. Danielson, B. S. P. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337054 · Cited by 772
Quinone chemistry and toxicity
Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., & Graham, D. G. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90273-u · Cited by 764
The Organic Chemistry of Drug Design and Drug Action
(1992) · Elsevier eBooks · doi:10.1016/c2009-0-22221-5 · Cited by 712
Levine, R. L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00765-7 · Cited by 658
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
ABC transporters: physiology, structure and mechanism – an overview
Higgins, C. F. (2001) · Research in Microbiology · doi:10.1016/s0923-2508(01)01193-7 · Cited by 641
Privileged Structures: Applications in Drug Discovery
DeSimone, R., Currie, K., Mitchell, S., Darrow, J., & Pippin, D. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328544 · Cited by 577
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
Galm, U., Hager, M. H., Van Lanen, S. G., Ju, J., Thorson, J. S., & Shen, B. (2005) · Chemical Reviews · doi:10.1021/cr030117g · Cited by 556
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A., Buettner, R., Proia, D., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526
Choi, C.-H. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-30 · Cited by 523
Antioxidant enzymes and their implications in pathophysiologic processes
Mates, J. M. (1999) · Frontiers in Bioscience · doi:10.2741/a432 · Cited by 520
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Sansone, P., & Bromberg, J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8907 · Cited by 515
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Matsuzawa, A., & Ichijo, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.011 · Cited by 502
NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
Bachur, N. R., Gordon, S. L., Gee, M. V., & Kon, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.2.954 · Cited by 489
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
Free radical formation by antitumor quinones
Powis, G. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90162-7 · Cited by 423
Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
Costantino, L., & Barlocco, D. (2006) · PubMed · Cited by 411
The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase
Kickhoefer, V. A., Siva, A. C., Kedersha, N. L., Inman, E. M., Ruland, C., Streuli, M., & Rome, L. H. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.917 · Cited by 405
Cellular pharmacology studies of shikonin derivatives
Chen, X., Yang, L., Oppenheim, J. J., & Howard, O. M. Z. (2002) · Phytotherapy Research · doi:10.1002/ptr.1100 · Cited by 401
NAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of β-Lapachone Cytotoxicity
Pink, J. J., Planchon, S. M., Tagliarino, C., Varnes, M. E., Siegel, D., & Boothman, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5416 · Cited by 376
Excisional surgery for cancer cure: therapy at a cost
Coffey, J., Wang, J., Smith, M., Bouchier-Hayes, D., Cotter, T., & Redmond, H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01282-8 · Cited by 374
Persidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 352
Vermilion, J. L., & Coon, M. J. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40876-3 · Cited by 346
Hollingshead, L. M., & Faulds, D. (1991) · Drugs · doi:10.2165/00003495-199142040-00010 · Cited by 345
Protein kinase B/Akt at a glance
Fayard, E., Tintignac, L. A., Baudry, A., & Hemmings, B. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02724 · Cited by 335
Cytotoxic Action of Juglone and Plumbagin: A Mechanistic Study Using HaCaT Keratinocytes
Inbaraj, J. J., & Chignell, C. F. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034132s · Cited by 335
The Chemical Biology of Naphthoquinones and Its Environmental Implications
Kumagai, Y., Shinkai, Y., Miura, T., & Cho, A. K. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134517 · Cited by 332
Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay
Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M., & Mylonakis, E. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030018 · Cited by 332
Li, R., Bianchet, M. A., Talalay, P., & Amzel, L. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8846 · Cited by 331
Parker, C., Waters, R., Leighton, C., Hancock, J., Sutton, R., Moorman, A. V., Ancliff, P., Morgan, M., Masurekar, A., Goulden, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62002-8 · Cited by 330
Privileged Structures as Leads in Medicinal Chemistry
Costantino, L., & Barlocco, D. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706775197999 · Cited by 330
The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers
Monks, T., & Jones, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337388 · Cited by 326
Introduction to Cancer Chemotherapeutics
Shewach, D. S., & Kuchta, R. D. (2009) · Chemical Reviews · doi:10.1021/cr900208x · Cited by 323
Smith, S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01780-1 · Cited by 314
Kasai, H., Yamaizumi, Z., Berger, M., & Cadet, J. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00050a078 · Cited by 300
Acquiring signalling specificity from the cytokine receptor gp130
Ernst, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.11.003 · Cited by 299
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
Siegel, D., Yan, C., & Ross, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.017 · Cited by 272
Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic
Lau, A. T. Y., Wang, Y., & Chiu, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21655 · Cited by 271
Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents
William Lown, J., Sim, S.-K., Majumdar, K. C., & Chang, R.-Y. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91557-1 · Cited by 260
Therapeutic attack of hypoxic cells of solid tumors: presidential address.
Sartorelli, A. C. (1988) · PubMed · Cited by 255
Decker, P., & Muller, S. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378265 · Cited by 242
Antifungal activity of Paraguayan plants used in traditional medicine.
Portillo, A., Vila, R., Freixa, B., Adzet, T., & Cañigueral, S. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00214-8 · Cited by 236
Matsui, A., Ikeda, T., Enomoto, K., Hosoda, K., Nakashima, H., Omae, K., Watanabe, M., Hibi, T., & Kitajima, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00424-3 · Cited by 232
Li, Y., Sun, X., LaMont, J. T., Pardee, A. B., & Li, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538044100 · Cited by 231
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
Sparreboom, A., Danesi, R., Ando, Y., Chan, J., & Figg, W. D. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00005-0 · Cited by 226
The Trypanocidal Activity of Naphthoquinones: A Review
Ventura Pinto, A., & Lisboa de Castro, S. (2009) · Molecules · doi:10.3390/molecules14114570 · Cited by 219
Hillard, E. A., de Abreu, F. C., Ferreira, D. C. M., Jaouen, G., Goulart, M. O. F., & Amatore, C. (2008) · Chemical Communications · doi:10.1039/b718116g · Cited by 216
Asche, C. V. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053765556 · Cited by 215
(1994) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-1833-4 · Cited by 202
Potential bioreductive alkylating agents. 1. Benzoquinone derivatives
Lin, A. J., Cosby, L. A., Shansky, C. W., & Sartorelli, A. C. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00282a011 · Cited by 198
Cellular Responses to DNA Damage in the Absence of Poly(ADP-ribose) Polymerase
Rhun, Y. L., Kirkland, J. B., & Shah, G. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8257 · Cited by 187
Cancer stemness and metastasis: Therapeutic consequences and perspectives
Monteiro, J., & Fodde, R. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.030 · Cited by 186
The mechanism of the degradation of DNA by streptonigrin
Cone, R., Hasan, S. K., Lown, J. W., & Morgan, A. R. (1976) · Canadian Journal of Biochemistry · doi:10.1139/o76-034 · Cited by 186
Classification of anticancer drugs—a new system based on therapeutic targets
Espinosa, E., Zamora, P., Feliu, J., & González Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00116-6 · Cited by 185
Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy.
Ullah, M. F. (2009) · PubMed · Cited by 180
Toyokuni, S., Mori, T., & Dizdaroglu, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570122 · Cited by 175
A Comparative Study on Anti-Inflammatory Activities of the Enantiomers, Shikonin and Alkannin
Tanaka, S., Tajima, M., Tsukada, M., & Tabata, M. (1986) · Journal of Natural Products · doi:10.1021/np50045a014 · Cited by 170
The role of hypoxia-activated prodrugs in cancer therapy
Denny, W. A. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00006-1 · Cited by 167
Li, C. J., Li, Y.-Z., Pinto, A. V., & Pardee, A. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13369 · Cited by 167
Tandon, V. K., Chhor, R. B., Singh, R. V., Rai, S., & Yadav, D. B. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.002 · Cited by 161
Recent Studies on Natural Products as Anticancer Agents
Ravelo, Á. G., Estévez‐Braun, A., Chávez, H., Pérez-Sacau, E., & Mesa‐Siverio, D. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451500 · Cited by 153
Dietary oxidative stress and antioxidant defense with an emphasis on plant extract administration
Veskoukis, A. S., Tsatsakis, A. M., & Kouretas, D. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0293-3 · Cited by 153
Generation of oxy radicals in biosystems
Simic, M. G., Bergtold, D. S., & Karam, L. R. (1989) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(89)90192-9 · Cited by 152
Inflammation, carcinogenesis and cancer
Fitzpatrick, F. A. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00102-3 · Cited by 147
Fujii, N., Yamashita, Y., Arima, Y., Nagashima, M., & Nakano, H. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2589 · Cited by 146
Salas, C. O., Tapia, R. A., Ciudad, K., Armstrong, V., Myriam Orellana, B., Kemmerling, U., Ferreira, J., Maya, J. D., & Morello, A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.038 · Cited by 132
Targeting Akt in cancer therapy
LoPiccolo, J., Granville, C. A., Gills, J. J., & Dennis, P. A. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280cc2c6f · Cited by 129
Pérez-Sacau, E., Díaz, R. G., Estévez‐Braun, A., Ravelo, Á. G., García-Castellano, J. M., Pardo, L., & Campillo, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060849b · Cited by 126
Pink, J. J., Wuerzberger‐Davis, S. M., Tagliarino, C., Planchon, S. M., Yang, X., Froelich, C. J., & Boothman, D. A. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4790 · Cited by 119
Geldanamycin. I. Structure assignment
RINEHART, K. L. J., Sasaki, K., Slomp, G., Grostic, M. F., & Olson, E. C. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00729a018 · Cited by 119
Nakamura, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg263 · Cited by 118
Shiloh, Y., Tabor, E., & Becker, Y. (1983) · Carcinogenesis · doi:10.1093/carcin/4.10.1317 · Cited by 111
Salas, C. O., Faúndez, M., Morello, A., Maya, J. D., & Tapia, R. A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986711793979779 · Cited by 111
Mitomycin C: a prototype bioreductive agent.
Sartorelli, A. C., Hodnick, W. F., Belcourt, M. F., Tomasz, M., Haffty, B. G., Jj, F., & Rockwell, S. (1994) · PubMed · Cited by 109
Free radicals in anticancer drug pharmacology
Sinha, B. K. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90117-8 · Cited by 107
Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
Ross, D., Beall, H. D., Traver, R. D., Siegel, D. M., Phillips, R. M., & Gibson, N. W. (1994) · PubMed · Cited by 106
Autophagy regulates ROS-induced cellular senescence via p21 in a p38 MAPKα dependent manner
Luo, Y., Zou, P., Zou, J., Wang, J., Zhou, D., & Liu, L. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.07.005 · Cited by 104
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
Beall, H. D., Mulcahy, R. T., Siegel, D. M., Traver, R. D., Gibson, N. W., & Ross, D. (1994) · PubMed · Cited by 102
Beall, H. D., Murphy, A.-M., Siegel, D. J., Hargreaves, R. H. J., Butler, J., & Ross, D. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10499-9 · Cited by 96
Design, synthesis, and studies of small molecule STAT3 inhibitors
Bhasin, D. K., Cisek, K. K., Pandharkar, T., Regan, N., Li, C., Pandit, B., Lin, J., & Li, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.031 · Cited by 88
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones
Bhasin, D. K., Chettiar, S. N., Etter, J. P., Mok, M., & Li, P. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.017 · Cited by 86
Bonifazi, E. L., Ríos‐Luci, C., León, L. G., Burton, G., Padrón, J. M., & Misico, R. I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.02.032 · Cited by 86
Mitoxantrone affects topoisomerase activities in human breast cancer cells
Crespi, M. D., Ivanier, S. E., Genovese, J. A., & Baldi, A. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90471-7 · Cited by 85
da Silva, A. J. M., Buarque, C. D., Brito, F. V., Aurelian, L., Macedo, L. F., Malkas, L. H., Hickey, R. J., Lopes, D. V. S., Noël, F., Murakami, Y. L. B., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00100-1 · Cited by 85
Liaudet, L., Szabó, É., Timashpolsky, L., Virág, L., Cziráki, A., & Szabó, C. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704185 · Cited by 84
Sasaki, T., Eguchi, S., & Ohno, M. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00713a050 · Cited by 82
Ai, L., Pardini, R. S., Cosby, L. A., Lillis, B. J., Shansky, C. W., & Sartorelli, A. C. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a010 · Cited by 82
Yang, F., Chen, Y., Duan, W., Zhang, C., Zhu, H., & Ding, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21943 · Cited by 81
A laccase-catalysed one-pot synthesis of aminonaphthoquinones and their anticancer activity
Wellington, K. W., & Kolesnikova, N. I. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.028 · Cited by 81
Self-citation5-Hydroxylapachol: a cytotoxic agent from Tectona grandis
Khan, R. M., & Mlungwana, S. M. (1999) · Phytochemistry · doi:10.1016/s0031-9422(98)00478-6 · Cited by 80
Walton, M. I., Wolf, C. R., & Workman, P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90007-6 · Cited by 79
Lawrence, H. R., Kazi, A., Luo, Y., Kendig, R. D., Ge, Y., Jain, S., Daniel, K. G., Santiago, D. N., Guida, W. C., & Sebti, S. M. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.038 · Cited by 76
Kalafungin. II. Chemical transformations and the absolute configuration.
Hoeksema, H., & Krueger, W. C. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.704 · Cited by 73
KALAFUNGIN, A NEW BROAD SPECTRUM ANTIBIOTIC
BERGY, M. E. (1968) · The Journal of Antibiotics · doi:10.7164/antibiotics.21.454 · Cited by 72
Preclinical and Clinical Studies of Lapachol and Beta-Lapachone
de Almeida, E. R. (2009) · The Open Natural Products Journal · doi:10.2174/1874848100902010042 · Cited by 71
Electron transfer in human cytochrome P450 reductase
Gutiérrez, A., Grunau, A., Paine, M. J. I., Munro, A. W., Wolf, C. R., Roberts, G. C. K., & Scrutton, N. S. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310497 · Cited by 68
Schreiber, J., Mottley, C., Sinha, B. K., Kalyanaraman, B., & Mason, R. P. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00236a009 · Cited by 67
Lethal Action and Metabolic Effects of Streptonigrin on Escherichia coli
White, H. L., & White, J. R. (1968) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12624-2 · Cited by 65
Kalyanaraman, B., Morehouse, K. M., & Mason, R. P. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90023-c · Cited by 64
Shaaban, S., Diestel, R., Hinkelmann, B., Muthukumar, Y., Verma, R. P., Sasse, F., & Jacob, C. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.09.033 · Cited by 61
Cytotoxic Effects of Mansonone E and F Isolated from Ulmus pumila
Wang, D., Xia, M., Cui, Z., Tashiro, S., Onodera, S., & Ikejima, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1025 · Cited by 61
Sensor/Effector Drug Design with Potential Relevance to Cancer
Fry, F. H., & Jacob, C. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010512 · Cited by 61
Bioactivation and Resistance to Mitomycin C
Seow, H. A., Penketh, P. G., Baumann, R. P., & Sartorelli, A. C. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82012-3 · Cited by 54
Of alphas and betas: distinct and overlapping functions of STAT3 isoforms
Dewilde, S. (2008) · Frontiers in Bioscience · doi:10.2741/3170 · Cited by 53
Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells
Kazi, A., Lawrence, H. R., Guida, W. C., McLaughlin, M. L., Springett, G. M., Berndt, N., Yip, R., & Sebti, S. M. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8798 · Cited by 53
Salustiano, E. J., Netto, C. D., Fernandes, R. F., da Silva, A. J. M., Bacelar, T. D. S., Castro, C. P., Buarque, C. D., Maia, R. C., Rumjanek, V. M., & Costa, P. R. R. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9231-y · Cited by 49
Isodiospyrin as a novel human DNA topoisomerase I inhibitor
Ting, C., Hsu, C.-T., Hsu, H.-T., Su, J.-S., Chen, T.-Y., Tarn, W., Kuo, Y., Whang‐Peng, J., Liu, L. F., & Hwang, J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.003 · Cited by 48
Stagliano, K. W., Emadi, A., Lu, Z., Malinakova, H. C., Twenter, B. M., Yu, M. L., Holland, L. E., Rom, A. M., Harwood, J. S., Amin, R., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.04.034 · Cited by 48
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors
Wu, W.-B., Ou, J., Huang, Z., Chen, S.-B., Ou, T., Tan, J., Li, D., Shen, L., Huang, S., Gu, L., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.04.059 · Cited by 47
Direct Reaction between Shikonin and Thiols Induces Apoptosis in HL60 Cells.
Gao, D., Hiromura, M., Yasui, H., & Sakurai, H. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.827 · Cited by 47
Pal, S., Jadhav, M. S., Weyhermüller, T., Patil, Y. P., Nethaji, M., Kasabe, U., Kathawate, L., Konkimalla, V. B., & Salunke‐Gawali, S. (2013) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2013.06.062 · Cited by 44
Synthesis and biological activity of novel shikonin analogues
Wang, W., Dai, M., Zhu, C.-H., Zhang, J. G., Lin, L., Ding, J., & Duan, W. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.032 · Cited by 44
Shin, D., Kim, S. N., Chae, J., Hyun, S., Seo, S., Lee, Y., Lee, K., Kim, S., Lee, Y., Jeong, J. M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.039 · Cited by 44
Lee, J. I., Choi, D. Y., Chung, H.-S., Seo, H. G., Woo, H. J., Choi, B. T., & Choi, Y. H. (2006) · PubMed · Cited by 43
β-Lapachone analogs with enhanced antiproliferative activity
Ríos‐Luci, C., Bonifazi, E. L., León, L. G., Montero, J. C., Burton, G., Pandiella, A., Misico, R. I., & Padrón, J. M. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.04.008 · Cited by 42
Portela, M. P. M., & Stoppani, A. O. M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02168-x · Cited by 41
First synthesis and anticancer activity of novel naphthoquinone amides
Pradidphol, N., Kongkathip, N., Sittikul, P., Boonyalai, N., & Kongkathip, B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.020 · Cited by 40
Distinct Roles of Cytochrome P450 Reductase in Mitomycin c Redox Cycling and Cytotoxicity
Wang, Y., Gray, J. P., Mishin, V. M., Heck, D. E., Laskin, D. L., & Laskin, J. D. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1098 · Cited by 40
Hao, X. Y., Widersten, M., Ridderström, M., Hellman, U., & Mannervik, B. (1994) · Biochemical Journal · doi:10.1042/bj2970059 · Cited by 36
Stressed tumor cell, chemosensitized cancer
Wiemer, E. A. C. (2011) · Nature Medicine · doi:10.1038/nm.2593 · Cited by 32
Netto, C. D., Salustiano, E. J., Castro, C. P., da Silva, A. J. M., Rumjanek, V. M., & Costa, P. R. R. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.027 · Cited by 32
Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity
Liu, Z., Huang, S., Li, M., Huang, Z., Lee, K. S. S., & Gu, L. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.002 · Cited by 32
Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones
Bhasin, D., Etter, J. P., Chettiar, S. N., Mok, M., & Li, P. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.098 · Cited by 29
Bioactivation of lapachol responsible for DNA scission by NADPH-cytochrome P450 reductase
Kumagai, Y., Tsurutani, Y., Shinyashiki, M., Homma‐Takeda, S., Nakai, Y., Yoshikawa, T., & Shimojo, N. (1997) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(97)00019-7 · Cited by 29
Campos, V. R., dos Santos, E. A., Ferreira, V. F., Montenegro, R. C., de Souza, M. C. B. V., Costa-Lotufo, L. V., de Moraes, M. O., Regufe, A. K. P., Jordão, A. K., Pinto, A. C., et al. (2012) · RSC Advances · doi:10.1039/c2ra21514d · Cited by 25
ATP ‐Binding Cassette ( ABC ) Transporters
Dean, M. C. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0713 · Cited by 17
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
Ross, A. E., Emadi, A., Marchionni, L., Hurley, P. J., Simons, B. W., Schaeffer, E. M., & Vuica‐Ross, M. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09907.x · Cited by 16
Viswanathan, U. M., Burkholz, T., & Jacob, C. (2013) · Zeitschrift für Physikalische Chemie · doi:10.1524/zpch.2013.0321 · Cited by 6
Induction of death of leukemia cells by TW-74, a novel derivative of chloro-naphthoquinone.
Hallak, M., Thakur, B. K., Win, T., Shpilberg, O., Bittner, S., Granot, Y., Levi, I., & Nathan, I. (2013) · PubMed · Cited by 5
Cited by
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents
Qiu, H., Wang, P., Lin, H., Tang, C., Zhu, H., & Yang, Y. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13141 · Cited by 118
Ma, J., Lim, C., Sacher, J. R., Van Houten, B., Qian, W., & Wipf, P. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.073 · Cited by 27
Metadata
- Authors
- Wellington, K. W.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 5
- Issue
- 26
- Pages
- 20309-20338
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W2017464987
- Cited by
- 316
- References
- 174
- FWCI
- 50.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.